RKRomanbek Kalmatov

Romanbek Kalmatov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Romanbek Kalmatov has a total of 137 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Water, Sanitation and Hygiene (WASH) Infrastructure and STEAM Education Capacity in Schools of Kyrgyzstan: A Socio-Economic Assessment and the Case for Public–Private Partnership

    by Gulnara Isaeva, Nurgul Kasenova, Amangeldi Zhumadilov, Gulmira Kudaiberdieva, Roman Kalmatov, Kudaiberdi Kozhobekov

    Adequate water, sanitation and hygiene (WASH) infrastructure and quality science, technology, engineering, arts and mathematics (STEAM) education are essential for human capital development in low- and middle-income countries. This study assesses WASH conditions and STEAM education capacity in 19 vulnerable schools across six regions of the Kyrgyz Republic using a mixed-methods approach. Data were collected from 109 school principals, teachers and administrative staff between June and August 2024 as part of an EU-funded project, complemented by field verification and desk research. The findings reveal significant infrastructure and capacity gaps. Only 22.5% of schools reported adequate sanitation facilities, 41.6% lacked hot water in sanitary facilities, and approximately one-third of respondents rated drinking-water availability as poor. Functional STEAM laboratories were largely absent, the student-to-computer ratio averaged 50:1, and only 23.6% of teachers considered themselves adequately prepared to integrate digital technologies. Infrastructure performance was evaluated using two original composite measures: the WASH Adequacy Index (WAI = 0.56) and the STEAM Capacity Index (SCI = 0.50), both substantially below the benchmark value of 0.75. The study also identifies systematic discrepancies between staff self-reports and independent field observations, suggesting social desirability and administrative-response bias in institutional assessments. Drawing on human capital theory and educational inequality perspectives, the article argues that inadequate infrastructure reinforces regional and gender disparities in educational opportunities. It proposes targeted public–private partnership (PPP) mechanisms to finance WASH facilities and STEAM laboratories and offers policy recommendations to support infrastructure investment, teacher professional development and monitoring systems aligned with Sustainable Development Goals.

  • Artificial Intelligence

    by Roman Kalmatov, Kudaiberdieva Gulmira Karimovna, Sheyshenov Zhamin, Fakher Rahim

  • Hormonal and Sexual Dysfunctions in Men Residing in Environmentally Unfavorable Conditions: A Clinical–Functional Analysis Using the ICF Framework

    by R. Kalmatov, T. Paizildaev, I. Ismailov, А. Omorova, A. Seitova

    Male reproductive health is increasingly recognized as a sensitive indicator of environmental and population health. The aim of this study was to comprehensively assess hormonal status and sexual function in men of reproductive age living in regions with various types of adverse environmental exposure, with functional interpretation of the findings within the framework of the International Classification of Functioning, Disability and Health (ICF). A comparative cross-sectional study was conducted involving 216 men aged 25–45 years who were permanent residents of either environmentally favorable regions or areas predominantly affected by pesticide use, heavy metal contamination, or radionuclide exposure. Hormonal assessment included measurements of total testosterone, sex hormone–binding globulin (SHBG), and luteinizing hormone (LH). Sexual function was evaluated using the International Index of Erectile Function (IIEF), with a focus on erectile and orgasmic domains. Within the ICF framework, environmental exposure is considered an adverse environmental factor leading to impairments in endocrine body functions and subsequent limitations in activity and participation, clinically manifested as sexual dysfunction. The findings support the interpretation of sexual dysfunction as an early functional marker of environmentally mediated endocrine disruption and highlight the value of integrating hormonal and functional outcomes in environmental and reproductive health research. Men residing in environmentally unfavorable regions exhibited significantly lower total testosterone levels and elevated SHBG concentrations compared with controls, while LH levels did not differ significantly between groups. These hormonal alterations were accompanied by marked reductions in erectile and orgasmic function scores. The observed combination of decreased androgen bioavailability in the absence of compensatory LH elevation indicates functional hypogonadism rather than primary testicular failure.

  • Pathophysiological Basis and Clinical Efficacy of Bariatric Surgery in Morbid Obesity and Metabolic Syndrome

    by E. Yrysbaev, A. Еshiev, E. Topchubaeva, R. Kalmatov, I. Atabaev

    Morbid obesity is a systemic endocrine-metabolic disease characterized by chronic low-grade inflammation, insulin resistance, hormonal dysregulation (hyperestrogenemia, hyperghrelinemia, reduced GLP-1/PYY), gut microbiota dysbiosis, and endothelial dysfunction. In Kyrgyzstan, the prevalence of obesity reaches 25–28%, with more than 40% of patients with BMI >35 kg/m² suffering from type 2 diabetes mellitus (T2DM). A systematic review of 68 studies (2010–2025), including 18 randomized controlled trials and large registries (SOS, LABS, etc.), was conducted. Bariatric/metabolic surgery (primarily sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB)) provides sustained loss of 50–75% of excess weight over 5–20 years, T2DM remission in 70–92% (RYGB) and 50–70% (LSG), arterial hypertension remission in 60–70 %, dyslipidemia normalization in 70–80%, and resolution/improvement of obstructive sleep apnea in 85–90%. A significant reduction in cardiovascular risk was demonstrated (overall mortality ↓49 %, cardiovascular mortality ↓59%, myocardial infarction ↓42%, stroke ↓36%) and obesity-associated cancer risk by 38–60% (endometrial cancer ↓62%, hepatocellular carcinoma ↓65%). RYGB shows superiority over LSG in metabolic, cardiovascular, and oncological outcomes due to a more pronounced incretin effect and gut microbiota remodeling. The contemporary safety profile (30-day mortality 0.08–0.3%) and rapid cost-effectiveness (payback period in Kyrgyzstan 2–3 years) confirm the method’s priority status. In cases of morbid obesity unresponsive to conservative treatment, bariatric surgery should be considered first-line therapy. In Kyrgyzstan and Central Asia, it is essential to establish a national registry, implement ERABS protocols, train specialists, and include these procedures in the mandatory health insurance system.

  • Open Access

    Molecular markers of endogenous neuroprotection in the brain of rats with experimental parkinson's disease treated with various pharmacotherapy regimens

    by Volodymyr Maramukha, Nataliia Buchakchyiska, Igor Belenichev, Valeria Tyshchenko, Kylychbek Mamasharipov, Romanbek Kalmatov, Lazokatkhan Dzhumaeva

    Aim: To study apoptotic processes and their role in the formation of premature dopaminergic neurodegeneration, to identify key biomarkers for early diagnosis and implementation of complex measures towards braking the progression of PD in the early stages, to develop possible treatment regimens with a specific neuroprotective effect on the dopaminergic system. Material and methods: The experiment involved 90 Wistar rats (6 months old, 220–290 g). Parkinsonism was induced by the neurotoxin MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Intact animals received saline (1 ml/100 g, i.p.); the control group received MPTP followed by saline. Rats were divided into nine groups: I – intact; II – PD control; III – PD + Amantadine (AM); IV – PD + AM + Cerebrocurin; V – PD + AM + Pramistar; VI – PD + AM + Gliatilin; VII – PD + AM + Noophen; VIII – PD + AM + Pronoran; IX – PD + AM + Melatonin. Results: The data obtained indicate that neuroprotective therapy of PD with drugs such as melatonin, cerebrocurin, pronoran, and gliatilin in combination with amantadine leads to an increase in the expression of the HIF-1α, HIF-3α, and HSP70 genes, and can also serve as a molecular marker for the activation of endogenous neuroprotection mechanisms under experimental PD conditions. Conclusions: We have experimentally demonstrated a new target of neuroprotection in PD conditions – apoptosis of dopamine-producing neurons and substantiated modulators of this process – drugs for combined therapy with amantadine (melatonin, cerebrocurin, pronoran, and gliatilin) as promising drugs for PD treatment.

  • Open Access

    The Umbrella Review of VDR Gene Polymorphism and the Risk of Diabetes and Possible Implications in Immunotherapy

    by Kalmatov Romanbek Kalmatovich, Karar Hassan Omran, Yousif Kadhim, Shatha Sadiq Al-Marayaty, Talib Kaleefa, Makhanbetkulova Dinara

    Systematic reviews and meta-analyses investigated VDR gene polymorphism correlations with T1D and T2D outcomes. We reviewed and meta-analyzed all VDR gene polymorphism research, including clinical outcome case-control studies. We conducted a comprehensive review using systematic data analysis to evaluate the association between VDR gene polymorphism and the risk of diabetes. According to the predefined search strategy and selection criteria, the article reporting the correlations of FokI polymorphisms and the risk of T1D included 40 papers (5,406 cases and 7,507 controls). Forty-three papers (10,252 cases and 9466 controls) focused on the associations between the FokI polymorphisms and T2D risk. The articles evaluated 10,252 cases and 9466 controls. Six meta-analyses linked the Fokl gene polymorphism to T1D and T2D. Summaries were nominally significant in 50% of observational meta-analyses. We demonstrated no association between VDR gene polymorphism and T1D risk across different ethnicities. T2D risk was also highly connected to the FokI polymorphism in Asian ethnicity. Gene-environment interactions must be investigated to understand these associations. The FokI polymorphism in the VDR gene has been extensively investigated, but more research is needed to know how VDR SNPs cause DM. Diabetes risk is linked to VDR gene polymorphism in this study. Diabetes risk is linked to the VDR gene polymorphism in this study. More research and well-planned studies are necessary for certainty.

  • Open Access

    Prevalence, incidence, mortality attributed to HIV in children under 5 years of age, and comparative analysis of health expenditure in central Asian countries

    by Kudaiberdi Gaparalievich Kozhobekov, Fakher Rahim, Roman Kalmatov, Khozhamkul Rabiga

    Background and Aim: Despite progress in HIV prevention and treatment in many regions, Eastern Europe and Central Asia continue to experience a rising epidemic, with a 20% increase in new HIV cases since 2010. Pediatric HIV remains a significant concern, with 13,000 children (0–14 years) living with HIV in Eastern Europe and Central Asia. Mother-to-child transmission (MTCT) rates in the region stand at 10%, far exceeding the global elimination targets of 2% (for non-breastfeeding mothers) and 5% (for breastfeeding mothers). However, country-specific, age-disaggregated data on pediatric HIV (prevalence, incidence, mortality, and ART coverage) remain scarce, hindering targeted interventions. This study aimed to assess the prevalence, incidence, and mortality of HIV among children under 5 years in Central Asia and evaluate health expenditures related to pediatric HIV treatment in the region. Methods: This descriptive study includes prevalence, incidence of HIV, and all deaths of children under 5 years of age living with HIV, in different regions covered by Central Asia during the years 1990 to 2021. Information was collected from the mortality registration system. Financial data on HIV-related health spending for each country of interest were gathered through the Development Assistance to Health (DAH) database. The model framework was based on the Global Burden of Disease (GBD) protocol. Results: There is a dramatic surge in HIV prevalence across Central Asia, from 4,776 cases in 1990 to over 1.5 million in 2019. Kazakhstan and Uzbekistan faced the most significant increases, while Georgia showed progress in reducing new infections, and Mongolia remained the least affected. Male children consistently had higher rates of HIV-related incidence and mortality. Notably, Uzbekistan experienced a rise in under-5 HIV-related mortality, from 10.06 per 100,000 in 1990 to 11.52 in 2019. Disparities in healthcare spending were evident, with Kazakhstan and Kyrgyzstan demonstrating more substantial investments, in contrast to lower per capita spending in Uzbekistan and Turkmenistan. Conclusion: Overall, the Central Asian region is experiencing a surge in HIV cases among children under 5 years of age, which contrasts with global trends. This may be attributed to disparities in healthcare spending, access to care, prevention efforts, and the stigma associated with HIV in Central Asia.


  • Artificial Intelligence

    by Roman Kalmatov, Kudaiberdieva Gulmira Karimovna, Sheyshenov Zhamin, Fakher Rahim

  • The Joint Role of Serum Markers of Congestion or Myocardial Necrosis And Speckle Tracking Echocardiography in The Detection of Early Subtle Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer

    by N. Raiimbek Uulu, I. V. Pershukov, L. V. Shulzhenko, B. A. Akbalaeva, T. A. Batyraliev, O. V. Gurovich, R. K. Kalmatov, S. M. Mamatova, N. T. Jainakbayev, A. O. Seidalin, et al.

    Aim To monitor the dynamics of biomarkers during chemotherapy, targeted chemotherapy and targeted monotherapy in patients with HER2-positive breast cancer (BC); to analyze the emergence timing of these changes; to compare early biochemical and echocardiographic criteria; and to determine the best time for assessing latent subclinical cardiac dysfunction. Material and methods Patients with BC (229 women aged 57±11 years) treated sequentially with anthracyclines, a combination of docetaxel and trastuzumab, and trastuzumab monotherapy were examined during three blocks of BC therapy until the development of clinical cardiotoxicity. Time-related changes in high-sensitivity cardiac troponin I, N-terminal pro-brain natriuretic peptide (NT-proBNP), left ventricular (LV) global longitudinal strain (GLS) and LV ejection fraction (EF) (up to 12 speckle-tracking echocardiograms/up to 12 laboratory tests) were analyzed. Clinical cardiotoxicity was defined as a symptomatic decrease in LV EF ≥10% from the baseline value of 54% or more. Results Clinically significant cardiotoxicity developed in 6.3-10.9% of cases depending on the treatment option for BC. Early manifestations of cardiotoxicity were detected already at 3 weeks after the start of the first course of chemotherapy. For the BC treatment with anthracyclines and targeted chemotherapy with docetaxel and trastuzumab, the markers of clinical cardiotoxicity were high-sensitivity cardiac troponin I, NT-proBNP and GLS LV. For the trastuzumab monotherapy, only GLS LV had a prognostic value. No statistically significant changes in the concentrations of high-sensitivity troponin I and NT-proBNP were found. Conclusion For timely detection of clinical cardiotoxicity, laboratory tests (high-sensitivity troponin I, NT-proBNP) and echocardiography (GLS LV) are recommended to be performed every 3 weeks before the next course of BC therapy. While doing so, their sensitivity will depend on the treatment option for BC.


  • Peculiarities of Manifestation and Modification of Cardiovascular Risk Factors in Urban and Rural Residents

    by I. Gulamov, R. Kalmatov, I. Ismailov, N. Raimbekuulu, T. Akhunbaeva

    Timely identification of risk factors is an important step towards reducing morbidity, since it will allow for the timely development of a set of treatment and preventive measures with minimal resource and economic costs, with minimal reduction in the quality of life of both the patient and his immediate environment. The main target guidelines are early detection of people with high risks of cardiovascular pathology, reduction of the level of impact of these factors, and maintenance of the highest possible percentage of people with a minimum level of risk of developing CVD. It is necessary to single out in a separate category people who have a history of diseases that can become a trigger for cardiovascular pathology. To study the current state of the problem of cardiovascular diseases (CVD) in rural and urban residents. The presented article is of a review nature, which determines the use of theoretical research methods. In writing the work, we used the following methodological approaches: meta-analysis of literary sources, critical and conceptual analysis. High blood pressure (BP), high glucose and cholesterol levels in the blood of patients are grounds for increased monitoring. It is important to identify the risk of developing atherosclerosis long before the first signs appear. Conclusions: risk factors should be assessed continuously and should be carried out whenever a patient seeks medical care. It is also important to involve local therapists in systematic monitoring of the cardiovascular system based on specially developed criteria for express diagnostics.